The Cost and burden of eye diseases and preventable blindness

Deloitte Access Economics

Research output: Book/ReportCommissioned report

Abstract

Conducted by Novartis, The European Forum Against Blindness (EFAB) and Deloitte Access Economics, "The Cost and Burden of Eye Diseases and Preventable Blindness" study quantified the economic impact of vision loss by analyzing the top four eye diseases responsible for vision loss: glaucoma, diabetic retinopathy, cataracts, and wet age-related macular degeneration (AMD), which, in the EU alone, affects one in 10 people. The study also analyzed the cost-effectiveness of interventions to prevent them. A total of 14 countries were included in the study: Australia, Argentina, Denmark, France, Germany, Ireland, Italy, Mexico, Poland, Slovak Republic, Spain, Sweden, Switzerland and the UK.
Original languageEnglish
Place of PublicationSydney
PublisherDeloitte
Commissioning bodyNovartis
Publication statusPublished - 2013
Externally publishedYes

Fingerprint Dive into the research topics of 'The Cost and burden of eye diseases and preventable blindness'. Together they form a unique fingerprint.

Cite this